Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Santander cuts BP; Berenberg likes Cairn Homes

Thu, 26th Feb 2026 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

----------

FTSE 100

----------

Citigroup raises Hiscox price target to 1,611 (1,430) pence - 'neutral'

----------

Berenberg raises Hiscox price target to 1,760 (1,580) pence - 'buy'

----------

RBC raises Hiscox price target to 1,710 (1,600) pence - 'outperform'

----------

Citigroup raises HSBC price target to 1,540 (1,370) pence - 'buy'

----------

UBS raises Standard Chartered price target to 2,167 (2,100) pence - 'buy'

----------

Deutsche Bank Research raises St James's Place price target to 2,000 (1,950) pence - 'buy'

----------

Barclays raises St James's Place target to 1,680 (1,565) pence - 'overweight'

----------

RBC raises St James's Place price target to 1,425 (1,375) pence - sector perform

----------

UBS raises Haleon price target to 478 (460) pence - 'buy'

----------

Goldman Sachs raises Haleon price target to 460 (440) pence - 'buy'

----------

Citigroup cuts Diageo price target to 2,200 (2,425) pence - 'buy'

----------

Bernstein cuts Diageo price target to 2,340 (2,360) pence - 'outperform'

----------

Barclays cuts Diageo price target to 2,310 (2,550) pence - 'overweight'

----------

UBS cuts Diageo price target to 1,730 (1,780) pence - 'neutral'

----------

Berenberg cuts Diageo price target to 2,230 (2,372) pence - 'buy'

----------

Barclays raises Tesco price target to 515 (500) pence - 'overweight'

----------

Berenberg raises Croda International price target to 3,600 (3,300) pence - 'buy'

----------

Barclays raises Croda International target to 3,400 (3,150) pence - 'overweight'

----------

UBS raises AstraZeneca price target to 17,600 (16,300) pence - 'buy'

----------

Santander cuts BP to 'neutral' (outperform) - price target 520 pence

----------

RBC raises Howden Joinery target to 900 (890) pence - 'sector perform'

----------

FTSE 250

----------

UBS cuts Mony Group price target to 166 (200) pence - 'neutral'

----------

Jefferies raises Hammerson price target to 340 (300) pence - 'hold'

----------

Kepler Cheuvreux cuts Aston Martin price target to 50 (60) pence - 'reduce'

----------

Deutsche Bank Research cuts Aston Martin price target to 65 (70) pence - 'hold'

----------

Panmure Liberum raises Genus price target to 3,700 (3,500) pence - 'buy'

----------

Berenberg raises Pan African price target to 190 (154) pence - 'buy'

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Investec starts Concurrent Technologies with 'buy' - price target 385 pence

----------

Berenberg starts Cairn Homes with 'buy' - price target 2.90 EUR

----------

Berenberg starts Glenveagh Properties with 'buy' - price target 2.70 EUR

----------

Deutsche Bank Research cuts Jet2 price target to 1,596 (1,857) pence - 'buy'

----------

Barclays cuts Jet2 price target to 1,900 (2,050) pence - 'overweight'

----------

Deutsche Bank Research raises Glanbia price target to 18.50 (17.50) EUR - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Broker Recommendations Market News Hiscox HSBC Holdings Standard Chartered St James's Place Diageo Haleon Tesco Croda International Astrazeneca BP Moneysupermarket.Com Aston Martin Lagonda Genus Pan African Resources Concurrent Technologies Cairn Homes Glenveagh Jet2 Glanbia

Shares in this article

Related News

Broker tips: Rosebank Industries, IntegraFin
15 hours ago

Broker tips: Rosebank Industries, IntegraFin

(Sharecast News) - Rosebank Industries rallied on Tuesday after both Citi and Jefferies reinstated coverage of the shares at 'buy'.

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit
16 hours ago

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit

(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant.

Shore Capital upgrades Transact owner IntegraFin to 'buy'
17 hours ago

Shore Capital upgrades Transact owner IntegraFin to 'buy'

(Sharecast News) - Shore Capital upgraded IntegraFin to 'buy' from 'hold' on Tuesday and lifted the price target to 400p from 350p as it said the Tran...